Skip to main content
. Author manuscript; available in PMC: 2022 Jul 3.
Published in final edited form as: Vaccine. 2019 Sep 20;37(44):6760–6767. doi: 10.1016/j.vaccine.2019.08.087

Table 4.

Selected clinical findings of Guillain Barré syndrome patients reported in VAERS following Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, October 2011 through July 2018.

Case
and
Year
Age
(Yr)
Sex
Recent History of
Illness
Vaccines Onset after
Adenovirus
vaccination
(days)
Diminished
DTR
CSF EMG and NCS Diagnosis Treatment Brighton
level
1 2011 24M URTI/sinusitis Adeno Hep A Hep B MMR Varicella (5 days prior IPV IIV MCV4) 31 2 wbc normal protein Consistent with AIDP/GBS GBS IVIG 2
2 2011 OBS STUDY 19-24M URTI Adeno (24 days prior MCV4 Tdap IIV Hep A) 2 Normal Consistent with GBS/AIDP GBS IVIG 2
3 2011 OBS STUDY ~22M URTI (1-2 weeks prior to onset of weakness) Adeno Hep A (5 days prior IIV Tdap MCV4 IPV) 31 Normal Consistent with AIDP/GBS GBS IVIG 2
4 2012 18M URTI Adeno Hep A/Hep B MCV4 Tdap 9 Not done Consistent with AIDP/GBS GBS IVIG Prednisolone 2
5 2012 27M URTI (1 week prior to onset of weakness) Adeno LAIV Tdap Hep A/Hep B MCV4 Varicella (35 days later Hep A/Hep B IPV Varicella) 42 1 wbc normal protein No record GBS IVIG 3
6 2012 20M URTI/sinusitis (2 weeks prior to onset of weakness) Adeno IIV IPV MCV4 Tdap (1 day prior Hep B MMR Varicella and 6 days later Hep A) 32 2 wbc elevated protein Inflammatory neuropathy GBS IVIG 1
7 2013 19F None Adeno Hep A/Hep B LAIV MCV4 Tdap 9 2483 rbc elevated protein (traumatic LP) No record (discussed with neurology team) GBS IVIG 3
8 2014 28F None Adeno Tdap MCV4 IIV 19 0 wbc normal protein Mild sensory neuropathy Atypical GBS IVIG 2
9 2014 25M URTI Adeno MCV4 Tdap 25 100 wbc normal protein AMSAN GBS AMSAN IVIG 2
10 2015 17M URTI Adeno LAIV MMR Tdap MCV4 (4 days later Varicella) 31 Not done No record GBS IVIG 3
11 2015 22M Bell’s palsy treated with prednisolone and valacyclovir Adeno Hep A LAIV Varicella Tdap MCV4 15 Normal DTRs 0 wbc elevated protein Mild axonal involvement GBS IVIG 1
12 2017 19M Bell’s palsy treated with prednisolone Adeno Tdap Varicella IPV Hep A/Hep B MCV4 IIV MMR 27 Hemolyzed specimen Not done Miller Fisher syndrome Steroid taper 3

Abbreviations used in this table: Yr = year, DTR = deep tendon reflexes, CSF = cerebrospinal fluid, EMG and NCS = electromyogram and nerve conduction study, M = male, F = female, URTI = upper respiratory tract infection, Adeno = adenovirus vaccine, Hep A = hepatitis A vaccine, Hep B = hepatitis B vaccine, MMR = measles mumps and rubella vaccine, IPV = inactivated poliovirus vaccine, IIV = inactivated influenza vaccine, MCV4 = meningococcal conjugate vaccine, √ = diminished DTRs, wbc = white blood cell, AIDP = acute inflammatory demyelinating polyneuropathy, GBS = Guillain Barré syndrome, IVIG = intravenous immunoglobulin, OBS = patient included in observational study, Tdap = tetanus diphtheria attenuated pertussis vaccine, Hep A/Hep B = combined hepatitis A and B vaccine, LAIV = live attenuated influenza vaccine, LP = lumbar puncture, AMSAN = acute motor sensory axonal neuropathy.

Brighton criterion for cytoalbuminologic dissociation is CSF protein elevation above laboratory normal value and CSF total wbc count <50 cells/ul.